Document Classification

Section Type: RESULTS

Text: Rofecoxib treated patients showed a significant increase in body weight (t (0) = 75. 31 + / - 4. 26 ; t (1) = 76. 54 + / - 4. 84 ; p : < 0. 001), systolic blood pressure (t (0) = 144 + / - 10. 86 ; t (1) = 154 + / - 11. 8 ; p < 0. 001), diastolic blood pressure (t (0) = 80 + / - 6. 05 ; t (1) = 89 + / - 7. 66 ; p < 0. 001) and serum sodium (t (0) = 138. 73 + / - 1. 28 ; t (1) = 140. 12 + / - 1. 80 ; p < 0. 005) associated with a significant decrease in the daily urine volume (t (0) = 1294. 64 + / - 205. 21 ; t, = 1, 115. 48 + / - 238. 47 ; p < 0. 001) and creatinine clearance (t (0) = 86. 73 + / - 8. 14 ; t (1) = 83. 15 + / - 7. 96 ; p < 0. 01).